Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine
Intraarterial PRRT safe in patients with meningioma
By
Will Morton
Intraarterial peptide receptor radionuclide therapy (PRRT) is a safe and effective alternative to intravenous PRRT in patients with advanced meningioma.
October 28, 2024
NNSA's Mo-99 program: A bumpy ride
By
Will Morton
Last year was a bumpy ride for a U.S. initiative to secure domestic supplies of molybdenum-99 (Mo-99).
October 10, 2024
How effective is Pluvicto in a âreal-worldâ setting?
By
Will Morton
Pluvicto appears to perform as effectively in prostate cancer patients in âreal-worldâ settings as it did in clinical trials prior to its approval.
September 20, 2024
SNMMI: PET-based protocol shows promise in radioligand therapy
By
Amerigo Allegretto
A PET-based scout dosimetry protocol can be feasible in treating lesions with yttrium-90 FAPI (Y-90 FAPI) radioligand therapy.
June 12, 2024
The rise of theranostics: Part 3 -- What is a theranostics center?
By
Liz Carey
For this third in a series covering the rise of theranostics,
AuntMinnie.com
asked four doctors of theranostics to discuss the spectrum of freestanding theranostics center development.
June 3, 2024
Can AI improve sustainability in nuclear medicine?
Nuclear medicine experts support the use of AI to improve sustainability of practices in the field, yet say implementation will require careful consideration of the technologyâs benefits and detriments.
April 9, 2024
The rise of theranostics: Part 2 -- Moving into communities
By
Liz Carey
In part 2 of The Rise of theranostics series, experts weigh in on getting started in prostate cancer theranostics as some private urology, radiation oncology practices, and radiologist groups begin building their abilities.
April 4, 2024
SNMMI to tackle Capitol Hill
By
AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) will host its annual Hill Day on April 5 in Washington, DC.
April 3, 2024
The rise of theranostics: Part 1 -- Gaining momentum
By
Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 19, 2024
Cannabis may influence bowel motility
By
Will Morton
Physicians, health care providers, and medical staff caring for patients who use cannabis should be familiar with the effects of the drug on gut motility, a recent report advises.
March 11, 2024
Hold off on the Egg McMuffins before GES tests, experts say
By
Will Morton
Nuclear medicine technologists are being advised that not just any meal works for patients before gastric emptying scintigraphy (GES).
March 7, 2024
Neiman HPI publishes advanced imaging prediction index
By
Kate Madden Yee
The Harvey L. Neiman Health Policy Institute (HPI) has developed and released a comorbidity index designed to help predict use of advanced imaging.
January 25, 2024
Page 1 of 436
Next Page